Exhibit 107.1
CALCULATION OF FILING FEE TABLES
Form S-8
Registration Statement Under
The Securities Act Of 1933
(Form Type)
Reata Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1 – Newly Registered Securities | |||||||
Security Type | Security Class Title | Fee Calculation Rule (2) | Amount Registered (1) | Proposed Maximum Offering Price Per Unit (2) | Maximum Aggregate Offering Price (2) | Fee Rate | Amount of registration fee (3) |
Equity | Class A common stock, par value $0.001 per share | Other | 1,601,487 | $51,407,733 | $92.70 per $1,000,000 | $4,765.50 | |
Equity | Class B common stock, par value $0.001 per share | Other | 1,601,487 | $32.10 | $51,407,733 | $92.70 per $1,000,000 | $0 |
Total Offering Amounts |
|
|
| $4,765.50 | |||
Total Fee Offsets |
|
|
| — | |||
Net Fee Due |
|
|
| $4,765.50 |
(2) | Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(h) under the Securities Act. The price for the Class A common stock and Class B common stock being registered hereby is based on a price of $32.10 |
per share of Class A common stock, which is the average of the high and low trading prices for a share of Class A common stock of the Registrant as reported on the NASDAQ Global Market on March 14, 2022. |
(3) | Pursuant to General Instruction E to Form S-8, a registration fee is only being paid with respect to the registration of an additional 1,601,487 aggregate shares of either Class A common stock or Class B common stock under the Plan. |